Strategies for Identifying Eligible Candidates for Anti-Amyloid Therapies

EP: 1.Burden of Alzheimer Disease and Key Stakeholders Involved in Care

EP: 2.Role of APPs in Alzheimer Disease Care in Community and Academic Settings

EP: 3.Strategies for Early Detection in Alzheimer Disease

EP: 4.Impact of Timely Alzheimer Diagnosis on Treatment Selection and Disease Progression

EP: 5.Operational Challenges With Early Identification in Alzheimer Disease

EP: 6.Opportunities for APPs to Lead Early Alzheimer Disease Care

EP: 7.Treatment Options in Alzheimer Disease

Now Viewing

EP: 8.Strategies for Identifying Eligible Candidates for Anti-Amyloid Therapies

Panelists discuss how identifying candidates for anti-amyloid therapy requires precise evaluation of disease stage, cognitive status, and biomarker confirmation. Advance practice providers (APPs) play an integral role in guiding patients through imaging and laboratory processes that establish eligibility.

Panelists discuss how comorbidities and risk factors influence candidacy, necessitating individualized assessment. Collaboration with physicians ensures adherence to safety standards and appropriate therapy selection.

Panelists discuss how patient and caregiver education is key to aligning expectations and promoting adherence. APPs provide clarity around potential benefits, limitations, and the need for continuous monitoring during treatment.